149 related articles for article (PubMed ID: 18586385)
21. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
22. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
23. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
Liu C; Qu L; Zhao C; Shou C
J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
[TBL] [Abstract][Full Text] [Related]
24. Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.
Cirak Y; Furuncuoglu Y; Yapicier O; Alici S; Argon A
Int J Clin Exp Pathol; 2015; 8(5):5345-53. PubMed ID: 26191236
[TBL] [Abstract][Full Text] [Related]
25. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
[TBL] [Abstract][Full Text] [Related]
26. [SNCG expression and clinical significance in colorectal cancer liver metastasis].
Guo CG; Sun LC; Liu Q; Xie YB; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):625-8. PubMed ID: 22736138
[TBL] [Abstract][Full Text] [Related]
27. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
28. Porous silicon surfaces: a candidate substrate for reverse protein arrays in cancer biomarker detection.
Ressine A; Corin I; Järås K; Guanti G; Simone C; Marko-Varga G; Laurell T
Electrophoresis; 2007 Dec; 28(23):4407-15. PubMed ID: 18041036
[TBL] [Abstract][Full Text] [Related]
29. [Construction, expression and immune response of eukaryotic plasmid secreting SNCG].
Meng L; Jiang B; Zhao W; Zhao L; Liu C; Wu J; Shou C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):626-30. PubMed ID: 20649033
[TBL] [Abstract][Full Text] [Related]
30. Characterization of de novo synthesized proteins released from human colorectal tumour explants.
Shi HJ; Stubbs R; Hood K
Electrophoresis; 2009 Jul; 30(14):2442-53. PubMed ID: 19639566
[TBL] [Abstract][Full Text] [Related]
31. Detection of colorectal disease by stool defensin assay: an exploratory study.
Zou H; Harrington JJ; Sugumar A; Klatt KK; Smyrk TC; Ahlquist DA
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):865-8. PubMed ID: 17531545
[TBL] [Abstract][Full Text] [Related]
32. Unconventional secretion of synuclein-γ promotes tumor cell invasion.
Liu C; Qu L; Lian S; Tian Z; Zhao C; Meng L; Shou C
FEBS J; 2014 Nov; 281(22):5159-71. PubMed ID: 25229320
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.
Min L; Zhang C; Ma R; Li X; Yuan H; Li Y; Chen R; Liu C; Guo J; Qu L; Shou C
BMC Cancer; 2016 Sep; 16(1):717. PubMed ID: 27595752
[TBL] [Abstract][Full Text] [Related]
34. Identification of γ-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry.
Zhao J; Xing N
Med Sci Monit; 2014 Dec; 20():2550-5. PubMed ID: 25479371
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
[TBL] [Abstract][Full Text] [Related]
36. Differential staining of γ synuclein in poorly differentiated compared to highly differentiated colon cancer cells.
Amsterdam A; Shezen E; Raanan C; Schreiber L; Slilat Y; Fabrikant Y; Melzer E
Oncol Rep; 2012 May; 27(5):1451-4. PubMed ID: 22294286
[TBL] [Abstract][Full Text] [Related]
37. [Preparation and characterization of human colon tumor-associated antigen and its clinical significance].
Liu XY; Yao XL; Song Y; Liu XY; Zhang P; Xu ZS; Song LH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):335-7. PubMed ID: 17428389
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
[TBL] [Abstract][Full Text] [Related]
39. [The correlation of synuclein-γ and matrix metalloproteinase 9 in breast cancer].
Chen J; Huang S; Wu KJ; Wang YK; Jia YJ; Lu YS; Weng ZY
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):641-4. PubMed ID: 24256593
[TBL] [Abstract][Full Text] [Related]
40. Expression of a 65 kDa oncofetal protein in human prostatic carcinoma.
Hanausek M; Walaszek Z; King TM; Amos CI
Oncol Rep; 2003; 10(5):1387-92. PubMed ID: 12883712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
